"Assertio is a pharmaceutical company that sells prescription products in 3 areas: neurology, hospital, and pain and inflammation. The company is currently undergoing major restructuring and has recently merged with Zyla Life Sciences. They have 7 FDA approved products in the marketplace.
Assertio currently has a market cap of only $150 million and has raised $50 million in direct offerings over the past week. ASRT has been on a bullish run with the price is currently up 45% in 1 week and it closed at $1.09 yesterday. This is despite 2 offerings that have been announced. The price skyrocketed off the closure of the first offering priced at $0.62 and I believe it will do the same with the current offering. Prior to the announcement of the recent offering (@$0.98), the price hit $1.45 on Tuesday. Given that the offering will not result in dilution, I believe any price under $1.1 is a good buy point"
Quoting - u/TruePriest
My target is 3$ depending on the earnings report next month. My RR ratio is 1:4
While we speak let's just avg down or up.
(Disclaimer)
(This is not financial advice, just my opinion)
Assertio currently has a market cap of only $150 million and has raised $50 million in direct offerings over the past week. ASRT has been on a bullish run with the price is currently up 45% in 1 week and it closed at $1.09 yesterday. This is despite 2 offerings that have been announced. The price skyrocketed off the closure of the first offering priced at $0.62 and I believe it will do the same with the current offering. Prior to the announcement of the recent offering (@$0.98), the price hit $1.45 on Tuesday. Given that the offering will not result in dilution, I believe any price under $1.1 is a good buy point"
Quoting - u/TruePriest
My target is 3$ depending on the earnings report next month. My RR ratio is 1:4
While we speak let's just avg down or up.
(Disclaimer)
(This is not financial advice, just my opinion)